MaxCyte, Inc. Earnings Per Share (Basic)
MaxCyte, Inc. (MXCT) reported Earnings Per Share (Basic) of -$0.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- MaxCyte, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.08.
- MaxCyte, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.04.
- MaxCyte, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.09.
- MaxCyte, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.12.
- MaxCyte, Inc. earnings per share, basic for fiscal 2025 was -$0.42.
- MaxCyte, Inc. earnings per share, basic for fiscal 2024 was -$0.39.
- MaxCyte, Inc. earnings per share, basic for fiscal 2023 was -$0.37.
- MaxCyte, Inc. earnings per share, basic for fiscal 2022 was -$0.23.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.08 10-Q · filed 2026-08-13 | -$0.13 10-Q · filed 2026-08-13 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.04 10-Q · filed 2026-05-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.37 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.42 10-K · filed 2026-03-25 |
| 2025-09-30 | -$0.12 10-Q · filed 2025-11-13 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.33 10-Q · filed 2025-11-13 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.12 10-Q · filed 2026-08-13 | -$0.21 10-Q · filed 2026-08-13 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.10 10-Q · filed 2026-05-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.30 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.39 10-K · filed 2026-03-25 |
| 2024-09-30 | -$0.11 10-Q · filed 2025-11-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.29 10-Q · filed 2025-11-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-06-30 | -$0.09 10-Q · filed 2025-08-06 | -$0.18 10-Q · filed 2025-08-06 | -$0.23 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.34 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2024-03-31 | -$0.09 10-Q · filed 2025-05-08 | -$0.14 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.25 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2025-11-13 |
| 2023-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.16 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-03-11 | -$0.37 10-K · filed 2025-03-11 |
| 2023-09-30 | -$0.11 10-Q · filed 2024-11-06 | -$0.21 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.32 10-Q · filed 2024-11-06 | -$0.36 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2023-06-30 | -$0.10 10-Q · filed 2024-08-06 | -$0.21 10-Q · filed 2024-08-06 | -$0.26 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2023-03-31 | -$0.11 10-Q · filed 2024-05-07 | -$0.15 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.22 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2022-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.19 derived: net income ÷ weighted average shares · filed 2024-03-12 | -$0.23 10-K · filed 2024-03-12 |
| 2022-09-30 | -$0.06 10-Q · filed 2023-11-08 | -$0.14 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.18 10-Q · filed 2023-11-08 | -$0.23 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-09 | -$0.12 10-Q · filed 2023-08-09 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-03-31 | -$0.04 10-Q · filed 2023-05-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.12 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$0.17 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2021-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.08 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.21 10-K · filed 2023-03-15 |
| 2021-09-30 | -$0.03 10-Q · filed 2022-11-09 | -$0.08 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.16 10-Q · filed 2022-11-09 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$0.05 10-Q · filed 2022-08-10 | -$0.14 10-Q · filed 2022-08-10 | -$0.17 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.22 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-03-31 | -$0.09 10-Q · filed 2022-05-09 | -$0.12 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.16 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2020-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$0.07 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$0.12 derived: net income ÷ weighted average shares · filed 2022-03-22 | -$0.17 10-K · filed 2022-03-22 |
| 2020-09-30 | -$0.04 10-Q · filed 2021-11-10 | -$0.09 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$0.14 10-Q · filed 2021-11-10 | |
| 2020-06-30 | -$0.05 10-Q · filed 2021-09-13 | -$0.10 10-Q · filed 2021-09-13 | ||
| 2019-12-31 | -$0.23 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |